Hormonal therapies and venous thrombosis: Considerations for prevention and management
Open Access
- 23 August 2022
- journal article
- review article
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 6 (6) , e12763
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysisCanadian Medical Association Journal, 2012
- Long-Term Evaluation of Cross-Sex Hormone Treatment in Transsexual PersonsThe Journal of Sexual Medicine, 2012
- A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormonesEuropean Journal of Endocrinology, 2011
- Epidemiology of the contraceptive pill and venous thromboembolismThrombosis Research, 2011
- Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal womenCurrent Opinion in Hematology, 2010
- Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-AnalysisThe Journal of Clinical Endocrinology & Metabolism, 2010
- Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2010
- Hormone therapy and thromboembolic diseaseCurrent Opinion in HIV and AIDS, 2007
- Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutationsBritish Journal of Haematology, 2007
- Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control studyThe Lancet, 1995